1. Chen, Yuanbing, Ning, Jieling, Shu, Long, Xia, Xuewei, Huang, Jun. 2024. CPLX2 is a novel tumor suppressor and improves the prognosis in glioma. In Journal of neuro-oncology, 167, 63-74. doi:10.1007/s11060-023-04548-4. https://pubmed.ncbi.nlm.nih.gov/38427133/
2. Zakharyan, Roksana, Atshemyan, Sofi, Boyajyan, Anna. . Risk and protective effects of the complexin-2 gene and gene-environment interactions in schizophrenia. In Recent advances in DNA & gene sequences, 8, 30-4. doi:. https://pubmed.ncbi.nlm.nih.gov/25564026/
3. Li, Hui, Zhao, Juan, Zhong, Xiao-Lan, Zhang, Cheng-Fang, Cao, Tian-Sheng. 2022. CPLX2 Regulates Ferroptosis and Apoptosis Through NRF2 Pathway in Human Hepatocellular Carcinoma Cells. In Applied biochemistry and biotechnology, 195, 597-609. doi:10.1007/s12010-022-04135-9. https://pubmed.ncbi.nlm.nih.gov/36107387/
4. Hass, Johanna, Walton, Esther, Kirsten, Holger, Calhoun, Vince D, Ehrlich, Stefan. 2014. Complexin2 modulates working memory-related neural activity in patients with schizophrenia. In European archives of psychiatry and clinical neuroscience, 265, 137-45. doi:10.1007/s00406-014-0550-4. https://pubmed.ncbi.nlm.nih.gov/25297695/
5. Begemann, Martin, Grube, Sabrina, Papiol, Sergi, Brose, Nils, Ehrenreich, Hannelore. . Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms. In Archives of general psychiatry, 67, 879-88. doi:10.1001/archgenpsychiatry.2010.107. https://pubmed.ncbi.nlm.nih.gov/20819981/
智鼠故事 
